The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Aberrant immune cell infiltrates and microcircumstances represent characteristic features of liver fibrosis. In this study, we profiled the transcriptomes of intrahepatic CD45+ immune cells, from mice, using single-cell RNA sequencing (scRNA-seq) technology to understand the landscape of intrahepatic immune cells during the pathogenesis of fibrosis. Analysis of approximately 10,000 single-cell transcriptomes revealed an increase in dendritic cells (DCs), macrophages, and neutrophils and a decrease in T and natural killer T (NKT) cells. In addition, we report changes in the transcriptomes of diverse immune cell types, implying a deteriorating intrahepatic immune microcircumstance. Furthermore, we uncovered a novel fibrosis-associated CD8 T (Ccl5+, Ccl4+) and CD4 T (mt-Co1+) cell subpopulation, which infiltrates fibrotic liver and is characterized by abnormal activation or inactivation as well as a TCR decline. The results from scRNA-seq and bulk immune repertoire sequencing (IR-seq) revealed an obvious decline in T cell receptor (TCR) clonotypes combined with shrinking VJ and VDJ segment usage, as well as lower complementarity-determining region 3 (CDR3) amino acid (AA) diversity from fibrotic liver. Interestingly, a deficiency of TCR IR (Tcrb KO mice) led to a deterioration of liver fibrosis, coupled with activation of hepatic stellate cells (HSCs) induced by the upregulation of macrophage and γδ T cell distribution in fibrotic Tcrb KO livers. Our findings reveal the landscape and dynamics of single immune cells in liver fibrosis, and clarify the protective role of TCR IR in response to chronic liver injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784
Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Mokdad, A. A., Lopez, A. D., Shahraz, S., Lozano, R., Mokdad, A. H., Stanaway, J., Murray, C. J., & Naghavi, M. (2014) · BMC Medicine · doi:10.1186/s12916-014-0145-y · Cited by 1,129
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Mechanisms of hepatic fibrogenesis
Lee, U. E., & Friedman, S. L. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.005 · Cited by 923
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
Schwabe, R. F., Tabas, I., & Pajvani, U. B. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.311 · Cited by 671
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Zhang, C.-Y., Yuan, W.-G., He, P., Lei, J.-H., & Wang, C.-X. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i48.10512 · Cited by 594
Inhibition of T–Cell Responses by Hepatic Stellate Cells Via B7–H1-Mediated T–Cell Apoptosis in Mice
Yu, M., Chen, C., Liang, X., Wang, L., Gandhi, C. R., Fung, J. J., Lu, L., & Qian, S. (2004) · Hepatology · doi:10.1002/hep.20488 · Cited by 301 · cited 2×
“In the present study, liver fibrogenesis resulted in a decrease in T cells via the upregulation of apoptosis-related genes in T cells, an observation that was consistent with previous findings (24, 38).”
BackgroundResultNLRP3 inflammasome driven liver injury and fibrosis: roles of IL-17 and TNF in mice
Wree, A., McGeough, M. D., Inzaugarat, M. E., Eguchi, A., Schuster, S., Johnson, C. D., Peña, C. A., Geisler, L. J., Papouchado, B. G., Hoffman, H. M., et al. (2018) · Hepatology · doi:10.1002/hep.29523 · Cited by 266
Safadi, R., Ohta, M., Alvarez, C. E., Fiel, M. I., Bansal, M., Mehal, W. Z., & Friedman, S. L. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.062 · Cited by 239
Research works printed but not linked: 31
- Stanaway, 2016, The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013, Lancet, 388, 10.1016/S0140-6736(16)30579-7 · DOI · Paper page
- Friedman, 2008, Mechanisms of hepatic fibrogenesis, Gastroenterology, 134, 10.1053/j.gastro.2008.03.003 · DOI · Paper page
- Parsons, 2007, Molecular mechanisms of hepatic fibrogenesis, J Gastroenterol Hepatol, 10.1111/j.1440-1746.2006.04659.x · DOI · Paper page
- Carson, 2018, Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells, Trends Parasitol, 34, 10.1016/j.pt.2018.02.005 · DOI
- Tsuchida, 2017, Mechanisms of hepatic stellate cell activation, Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38 · DOI · Paper page
- Higashi, 2017, Hepatic stellate cells as key target in liver fibrosis, Adv Drug Deliv Rev, 121, 27, 10.1016/j.addr.2017.05.007 · DOI · Paper page
- Wahid, 2018, Role of altered immune cells in liver diseases: a review, Gastroenterol y Hepatol, 41, 10.1016/j.gastrohep.2018.01.014 · DOI
- Tosello-Trampont, 2017, Immunoregulatory Role of NK Cells in Tissue Inflammation and Regeneration, Front Immunol, 8, 10.3389/fimmu.2017.00301 · DOI · Paper page
- Wang, 2018, gammadelta T cells in liver diseases, Front Med, 12, 10.1007/s11684-017-0584-x · DOI
- Kim, 2018, Allyl isothiocyanate reduces liver fibrosis by regulating Kupffer cell activation in rats, J Vet Med Sci, 80, 10.1292/jvms.17-0637 · doi:10.1292/jvms.17-0637
- Liu, 2018, Relationship between PK2 and number of Kupffer cells during the progression of liver fibrosis in patients with HBV, Turk J Med Sci, 48, 52, 10.3906/sag-1705-32 · DOI
- Zheng, 2017, Recruitment of Neutrophils Mediated by Vgamma2 gammadelta T Cells Deteriorates Liver Fibrosis Induced by Schistosoma japonicum Infection in C57BL/6 Mice, Infect Immun, 85, 1, 10.1128/IAI.01020-16 · DOI
- Liang, 2018, Intrahepatic T cell receptor beta immune repertoire is essential for liver regeneration, Hepatology, 68, 10.1002/hep.30067 · DOI
- Georgiev, 2007, Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse, Gut, 56, 10.1136/gut.2006.097170 · DOI
- Maricic, 2015, Inhibition of type I natural killer T cells by retinoids or following sulfatide-mediated activation of type II natural killer T cells attenuates alcoholic liver disease in mice, Hepatology, 61, 10.1002/hep.27632 · DOI · Paper page
- Katz, 2011, Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis, J Immunol, 187, 10.4049/jimmunol.1004077 · DOI · Paper page
- Liu, 2014, [Changes of regulatory T cells related to CCl(4)-induced liver fibrosis in mice], Zhonghua Gan Zang Bing Za Zhi, 22, 10.3760/cma.j.issn.1007-3418.2014.04.008 · doi:10.3760/cma.j.issn.1007-3418.2014.04.008
- Azizi, 2018, Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment, Cell, 174, 1293, 10.1016/j.cell.2018.05.060 · DOI · Paper page
- Pellicoro, 2014, Liver fibrosis and repair: immune regulation of wound healing in a solid organ, Nat Rev Immunol, 14, 10.1038/nri3623 · DOI · Paper page
- Iredale, 2014, Identifying molecular factors that contribute to resolution of liver fibrosis, Gastroenterology, 146, 10.1053/j.gastro.2014.03.019 · DOI
- Campana, 2017, Regression of Liver Fibrosis, Semin Liver Dis, 37, 1, 10.1055/s-0036-1597816 · DOI · Paper page
- Weiskirchen, 2014, Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology, Hepatobiliary Surg Nutr, 3, 10.3978/j.issn.2304-3881.2014.11.03 · doi:10.3978/j.issn.2304-3881.2014.11.03 · Paper page
- Guillot, 2019, Liver Macrophages: Old Dogmas and New Insights, Hepatol Commun, 3, 10.1002/hep4.1356 · DOI · Paper page
- Chinnadurai, 2010, B7-H4 mediates inhibition of T cell responses by activated murine hepatic stellate cells, Hepatology, 52, 10.1002/hep.23953 · DOI · Paper page
- Shen, 2017, Thymic NF-kappaB-inducing kinase regulates CD4(+) T cell-elicited liver injury and fibrosis in mice, J Hepatol, 67, 10.1016/j.jhep.2017.02.025 · DOI
- Liaskou, 2016, High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires, Hepatology, 63, 10.1002/hep.28116 · DOI
- Chen, 2016, High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC, Oncoimmunology, 5, 10.1080/2162402X.2016.1219010 · DOI
- Jiang, 2018, Analysis of T cell receptor repertoire in monozygotic twins concordant and discordant for chronic hepatitis B infection, Biochem Biophys Res Commun, 497, 10.1016/j.bbrc.2018.02.043 · DOI
- Huang, 2016, Analysis of the complementarity determining regions beta-chain genomic rearrangement using high-throughput sequencing in periphery cytotoxic T lymphocytes of patients with chronic hepatitis B, Mol Med Rep, 14, 10.3892/mmr.2016.5329 · doi:10.3892/mmr.2016.5329
- Secchi, 2017, Heparanase and macrophage interplay in the onset of liver fibrosis, Sci Rep, 7, 14956, 10.1038/s41598-017-14946-0 · DOI
- Xiao, 2017, Mucosal-Associated Invariant T Cells: New Insights into Antigen Recognition and Activation, Front Immunol, 8, 10.3389/fimmu.2017.01540 · DOI
Cited by
Targeting fibrosis: mechanisms and clinical trials
Zhao, M., Wang, L., Wang, M., Zhou, S., Lu, Y., Cui, H., Racanelli, A. C., Zhang, L., Ye, T., Ding, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01070-3 · Cited by 547
Opioid-induced fragile-like regulatory T cells contribute to withdrawal
Zhu, Y., Yan, P., Wang, R., Lai, J., Tang, H., Xiao, X., Yu, R., Bao, X., Zhu, F., Wang, K., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.030 · Cited by 73
Self-citationMacrophage-Derived Cathepsin S Remodels the Extracellular Matrix to Promote Liver Fibrogenesis
Zuo, T., Xie, Q., Liu, J., Yang, J., Shi, J., Kong, D., Wang, Y., Zhang, Z., Gao, H., Zeng, D.-B., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.05.039 · Cited by 70
Self-citationWang, R., Liang, Q., Zhang, Q., Zhao, S., Lin, Y., Liu, B., Ma, Y., Mai, X., Fu, Q., Bao, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202403849 · Cited by 25
Self-citation
Metadata
- Authors
- Liang, Q., Hu, Y., Zhang, M., Lin, C., Zhang, W., Li, Y., Zhu, P., Xue, P., Chen, Y., Li, Q., & Wang, K.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-18
- Volume
- 11
- Pages
- 584979-584979
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3111736262
- Cited by
- 17
- References
- 17
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Natural Science Foundation of China (81900569)
- Fundamental Research Funds for the Central Universities
- National Postdoctoral Program for Innovative Talents
- China Postdoctoral Science Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution. https://app.cochat.ai/papers/10.3389/fimmu.2020.584979
- The paper
- Liang, Q., Hu, Y., Zhang, M., Lin, C., Zhang, W., Li, Y., Zhu, P., Xue, P., Chen, Y., Li, Q., & Wang, K. (2020). The T Cell Receptor Immune Repertoire Protects the Liver From Reconsitution. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.584979
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.